Literature DB >> 8512534

Quantitative trait loci (QTL) applications to substances of abuse: physical dependence studies with nitrous oxide and ethanol in BXD mice.

J K Belknap1, P Metten, M L Helms, L A O'Toole, S Angeli-Gade, J C Crabbe, T J Phillips.   

Abstract

Recombinant inbred (RI) mouse strains were developed primarily as a tool to detect and provisionally map major gene loci--those with effects large enough to cause a bimodal distribution in the trait of interest. This implied that progress toward gene mapping was possible only for gene loci accounting for at least half of the genetic variance. More recently, QTL (quantitative trait loci) approaches have been advanced that do not require bimodal distributions and are thus applicable to a much wider range of phenotypes. They offer the prospect of meaningful progress toward detecting and mapping minor as well as major gene loci affecting any trait of interest, provided there is a significant degree of genetic determination among the RI strains. This paper presents a review of RI gene mapping efforts concerning phenotypes related to drug abuse and presents new data for studies now in progress for nitrous oxide and acute ethanol withdrawal intensity. These two studies exemplify several strengths and limitations of the RI QTL approach.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8512534     DOI: 10.1007/BF01067426

Source DB:  PubMed          Journal:  Behav Genet        ISSN: 0001-8244            Impact factor:   2.805


  40 in total

1.  Acute dependence on depressant drugs is determined by common genes in mice.

Authors:  J C Crabbe; C Merrill; J K Belknap
Journal:  J Pharmacol Exp Ther       Date:  1991-05       Impact factor: 4.030

Review 2.  Use of recombinant inbred strains to identify quantitative trait loci in psychopharmacology.

Authors:  G Gora-Maslak; G E McClearn; J C Crabbe; T J Phillips; J K Belknap; R Plomin
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 3.  Empirical estimates of Bonferroni corrections for use in chromosome mapping studies with the BXD recombinant inbred strains.

Authors:  J K Belknap
Journal:  Behav Genet       Date:  1992-11       Impact factor: 2.805

Review 4.  Effects of high pressure on the central nervous system.

Authors:  M J Halsey
Journal:  Physiol Rev       Date:  1982-10       Impact factor: 37.312

5.  Potencies of inhaled anesthetics and alcohol in mice selectively bred for resistance and susceptibility to nitrous oxide anesthesia.

Authors:  D D Koblin; J E Deady; E I Eger
Journal:  Anesthesiology       Date:  1982-01       Impact factor: 7.892

6.  A linkage map of endogenous murine leukemia proviruses.

Authors:  W N Frankel; J P Stoye; B A Taylor; J M Coffin
Journal:  Genetics       Date:  1990-02       Impact factor: 4.562

7.  Inheritance of amphetamine-induced thermoregulatory responses in inbred mice.

Authors:  T W Seale; J M Carney; P Johnson; O M Rennert
Journal:  Pharmacol Biochem Behav       Date:  1985-09       Impact factor: 3.533

Review 8.  Genetic correlations among ethanol-related behaviors and neurotensin receptors in long sleep (LS) x short sleep (SS) recombinant inbred strains of mice.

Authors:  V G Erwin; B C Jones
Journal:  Behav Genet       Date:  1993-03       Impact factor: 2.805

9.  Mice tolerant to nitrous oxide are also tolerant to alcohol.

Authors:  D D Koblin; J E Deady; D E Dong; E I Eger
Journal:  J Pharmacol Exp Ther       Date:  1980-05       Impact factor: 4.030

10.  Pharmacogenetics of phenylethylamine: determination of heritability and genetic transmission of locomotor effects in recombinant inbred strains of mice.

Authors:  D V Jeste; D M Stoff; R Rawlings; R J Wyatt
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

View more
  27 in total

1.  Quantitative trait loci involved in genetic predisposition to acute alcohol withdrawal in mice.

Authors:  K J Buck; P Metten; J K Belknap; J C Crabbe
Journal:  J Neurosci       Date:  1997-05-15       Impact factor: 6.167

Review 2.  Pharmacogenetic studies of alcohol self-administration and withdrawal.

Authors:  John C Crabbe; Tamara J Phillips
Journal:  Psychopharmacology (Berl)       Date:  2003-10-09       Impact factor: 4.530

Review 3.  Human and laboratory rodent low response to alcohol: is better consilience possible?

Authors:  John C Crabbe; Richard L Bell; Cindy L Ehlers
Journal:  Addict Biol       Date:  2010-04       Impact factor: 4.280

4.  Localization of genes mediating acute and sensitized locomotor responses to cocaine in BXD/Ty recombinant inbred mice.

Authors:  T J Phillips; M G Huson; C S McKinnon
Journal:  J Neurosci       Date:  1998-04-15       Impact factor: 6.167

5.  Genetic and environmental control of variation in retinal ganglion cell number in mice.

Authors:  R W Williams; R C Strom; D S Rice; D Goldowitz
Journal:  J Neurosci       Date:  1996-11-15       Impact factor: 6.167

Review 6.  Using expression genetics to study the neurobiology of ethanol and alcoholism.

Authors:  Sean P Farris; Aaron R Wolen; Michael F Miles
Journal:  Int Rev Neurobiol       Date:  2010       Impact factor: 3.230

7.  Quantitative trait loci associated with the behavioral response of B x D recombinant inbred mice to restraint stress: a preliminary communication.

Authors:  B J Tarricone; J N Hingtgen; J K Belknap; S R Mitchell; J I Nurnberger
Journal:  Behav Genet       Date:  1995-09       Impact factor: 2.805

8.  Performance of C57BL/6J and DBA/2J mice on a touchscreen-based attentional set-shifting task.

Authors:  Price E Dickson; Michele A Calton; Guy Mittleman
Journal:  Behav Brain Res       Date:  2013-12-18       Impact factor: 3.332

9.  Microarray analysis of mouse brain gene expression following acute ethanol treatment.

Authors:  Julie A Treadwell; Shiva M Singh
Journal:  Neurochem Res       Date:  2004-02       Impact factor: 3.996

10.  Mapping quantitative trait loci mediating sensitivity to etomidate.

Authors:  Chris Downing; Elaine H Shen; Victoria J Simpson; Thomas E Johnson
Journal:  Mamm Genome       Date:  2003-06       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.